149 related articles for article (PubMed ID: 20696857)
1. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS.
Shaykhiev R; Sierigk J; Herr C; Krasteva G; Kummer W; Bals R
FASEB J; 2010 Dec; 24(12):4756-66. PubMed ID: 20696857
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.
Holani R; Babbar A; Blyth GAD; Lopes F; Jijon H; McKay DM; Hollenberg MD; Cobo ER
Gut Microbes; 2020 Nov; 12(1):1785802. PubMed ID: 32658599
[TBL] [Abstract][Full Text] [Related]
3. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.
Pistolic J; Cosseau C; Li Y; Yu JJ; Filewod NC; Gellatly S; Rehaume LM; Bowdish DM; Hancock RE
J Innate Immun; 2009; 1(3):254-67. PubMed ID: 20375583
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenol epigallocatechin-3-gallate and cranberry proanthocyanidins act in synergy with cathelicidin (LL-37) to reduce the LPS-induced inflammatory response in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts.
Lombardo Bedran TB; Palomari Spolidorio D; Grenier D
Arch Oral Biol; 2015 Jun; 60(6):845-53. PubMed ID: 25791329
[TBL] [Abstract][Full Text] [Related]
5. Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation.
Suzuki K; Murakami T; Hu Z; Tamura H; Kuwahara-Arai K; Iba T; Nagaoka I
J Immunol; 2016 Feb; 196(3):1338-47. PubMed ID: 26729811
[TBL] [Abstract][Full Text] [Related]
6. The human Cathelicidin LL-37 induces MUC5AC mucin production by airway epithelial cells via TACE-TGF-α-EGFR pathway.
Zhang Y; Zhu M; Yang Z; Pan X; Jiang Y; Sun C; Wang Q; Xiao W
Exp Lung Res; 2014 Sep; 40(7):333-42. PubMed ID: 24901072
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
[TBL] [Abstract][Full Text] [Related]
8. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide.
Golec M
Ann Agric Environ Med; 2007; 14(1):1-4. PubMed ID: 17655171
[TBL] [Abstract][Full Text] [Related]
9. Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.
Suzuki K; Murakami T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
Int Immunol; 2011 Mar; 23(3):185-93. PubMed ID: 21393634
[TBL] [Abstract][Full Text] [Related]
10. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis.
Sandgren S; Wittrup A; Cheng F; Jönsson M; Eklund E; Busch S; Belting M
J Biol Chem; 2004 Apr; 279(17):17951-6. PubMed ID: 14963039
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.
Tjabringa GS; Aarbiou J; Ninaber DK; Drijfhout JW; Sørensen OE; Borregaard N; Rabe KF; Hiemstra PS
J Immunol; 2003 Dec; 171(12):6690-6. PubMed ID: 14662872
[TBL] [Abstract][Full Text] [Related]
12. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.
Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF
Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631
[TBL] [Abstract][Full Text] [Related]
13. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa.
Byfield FJ; Kowalski M; Cruz K; Leszczyńska K; Namiot A; Savage PB; Bucki R; Janmey PA
J Immunol; 2011 Dec; 187(12):6402-9. PubMed ID: 22095714
[TBL] [Abstract][Full Text] [Related]
14. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity.
Yoshioka M; Fukuishi N; Kubo Y; Yamanobe H; Ohsaki K; Kawasoe Y; Murata M; Ishizumi A; Nishii Y; Matsui N; Akagi M
Biol Pharm Bull; 2008 Feb; 31(2):212-6. PubMed ID: 18239275
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes.
Schromm AB; Paulowski L; Kaconis Y; Kopp F; Koistinen M; Donoghue A; Keese S; Nehls C; Wernecke J; Garidel P; Sevcsik E; Lohner K; Sanchez-Gomez S; Martinez-de-Tejada G; Brandenburg K; Brameshuber M; Schütz GJ; Andrä J; Gutsmann T
Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34183393
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism.
Hu Z; Murakami T; Suzuki K; Tamura H; Kuwahara-Arai K; Iba T; Nagaoka I
PLoS One; 2014; 9(1):e85765. PubMed ID: 24454930
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory Cytokines Impair Vitamin D-Induced Host Defense in Cultured Airway Epithelial Cells.
Schrumpf JA; Amatngalim GD; Veldkamp JB; Verhoosel RM; Ninaber DK; Ordonez SR; van der Does AM; Haagsman HP; Hiemstra PS
Am J Respir Cell Mol Biol; 2017 Jun; 56(6):749-761. PubMed ID: 28231019
[TBL] [Abstract][Full Text] [Related]
18. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease.
Jiang YY; Xiao W; Zhu MX; Yang ZH; Pan XJ; Zhang Y; Sun CC; Xing Y
Respir Med; 2012 Dec; 106(12):1680-9. PubMed ID: 22981321
[TBL] [Abstract][Full Text] [Related]
19. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro.
Ciornei CD; Egesten A; Bodelsson M
Acta Anaesthesiol Scand; 2003 Feb; 47(2):213-20. PubMed ID: 12631052
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations.
Bogdanov IV; Streltsova MA; Kovalenko EI; Sapozhnikov AM; Panteleev PV; Ovchinnikova TV
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
